Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-14

Clinical Trial Update: The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR) [Phase 4]

View source ↗

Summary

The HONOR Phase 4 trial comparing candesartan to losartan in hypertension with heart failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Candesartan (Atacand) (candesartan)
  • Losartan (Cozaar) (losartan)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertension | Phase 4 | Status: TERMINATED